Eslify 800 Tablet

Produktübersicht

About Eslify 800 Tablet

Eslify 800 Tablet is a medication containing the active ingredient Eslicarbazepine, classified as Anticonvulsant medication. Eslicarbazepine acetate (ESL), sold under the brand names Aptiom and Zebinix among others, is an anticonvulsant medication approved for use in Europe and the United States as monotherapy or as additional therapy for partial-onset seizures epilepsy.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Eslicarbazepine acetate tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older
• Used for: Eslicarbazepine acetate tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Eslicarbazepine, the active ingredient in Eslify 800 Tablet, belongs to the Anticonvulsant medication class. 1 INDICATIONS AND USAGE Eslicarbazepine acetate tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older. Eslicarbazepine acetate tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Eslify 800 Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Eslify 800 Tablet for extended periods without medical advice.